Ausgabe 1/2009
Inhalt (7 Artikel)
The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis
Juergen Thiele, Hans Michael Kvasnicka
Use of alemtuzumab and rituximab consolidation in CLL: Pros and cons
Thomas Elter, Barbara F. Eichhorst, Clemens-Martin Wendtner
Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia
Anders Österborg, Claes Karlsson, Jeanette Lundin